A matched-control evaluation of an antifungal bundle in the intensive care unit at a university teaching hospital

International Journal of Clinical Pharmacy

Volumn 35, Issue 1, 2013, Pages 145-148

  Guarascio, Anthony J ^a   Slain, Douglas ^b   McKnight, Richard ^b   Petros, Karen ^b   Parker, John ^c   Wilson, Alison ^c   Defazio, Carrie M ^b   Sarwari, Arif R ^c  

^a UNIVERSITY OF TENNESSEE   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; CASPOFUNGIN; ECHINOCANDIN; FLUCONAZOLE;

ADULT; ANTIMICROBIAL THERAPY; ARTICLE; AWARENESS; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CLINICAL PROTOCOL; CONTROLLED STUDY; DEMOGRAPHY; DRUG CONTROL; DRUG COST; DRUG USE; FEMALE; HOSPITAL PATIENT; HUMAN; INTENSIVE CARE UNIT; MALE; MEDICAL ASSESSMENT; MEDICATION THERAPY MANAGEMENT; MYCOSIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; TEACHING HOSPITAL; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT PLANNING;

ADULT; ANTIFUNGAL AGENTS; ECHINOCANDINS; FEMALE; HOSPITALS, TEACHING; HOSPITALS, UNIVERSITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED;

EID: 84874664364     PISSN: 22107703     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11096-012-9712-5     Document Type: Article

References (10)

1. Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis. 1999;29:239-44.
2. Pappas PG, Kauffman CA, Andes D, Benjamin DK, Calandra TF, Edwards JE, et al. Clinical practice guidelines for the management of candidiasis: 2009 update by the infectious diseases society of America. Clin Infect Dis. 2009;48(5):503-35.
3. Pfaller MA, Messer SA, Moet GJ, Jones RN, Castanheria M. Candida bloodstream infections: comparison of species distribution and resistance to echinocandin and azole antifungal agents in intensive care (ICU) and non-ICU settings in the SENTRY antimicrobial surveillance program (2008-2009). Int J Antimicrob Chemother. 2011;38:65-9.
4. Lichtenstern C, Nguyen TH, Schemmer P, Hoppe-Tichy T, Weigand MA. Efficacy of caspofungin in invasive candidiasis and candidemia-de-escalation strategy. Mycoses. 2008;51(Suppl 1):35-46.
5. Shah DN, Yau R, Weston J, Lasco TM, Salazar M, Palmer HR, et al. Evaluation of antifungal therapy in patients with candidaemia based on susceptibility testing results: implications for antimicrobial stewardship programmes. J Antimicrob Chemother. 2011;66:2146-51.
6. Spellberg BJ, Scott GF, Edwards JE. Current treatment strategies for disseminated candidiasis. Clin Infect Dis. 2006;42(2):244-51.
7. Dellit TH, Owens RC, McGowan JE, Gerding DN, Weinstein RA, Burke JP, et al. Infectious diseases society of America and the society for healthcare epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis. 2007;44:159-77.
8. Cooke FJ, Holmes AH. The missing care bundle: antibiotic prescribing in hospitals. Int J Antimicrob Agents. 2007;30(1):25-9.
9. Pulcini C, Defres S, Aggarwal I, Nathwani D, Davey P. Design of a 'day 3 bundle' to improve the reassessment of inpatient empirical antibiotic prescriptions. J Antimicrob Chemother. 2008;61(6):1384-8.
10. Toth NR, Chambers RM, Davis SL. Implementation of a care bundle for antimicrobial stewardship. Am J Health-Syst Pharm. 2010;67:746-9.